• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Sunday 04/22/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

cancer

  • 2:42 PM

    Cannabics patent granted with enabling technology to personalize Cannabinoid diagnostics and treatment for Cancer patients PR Newswire TEL AVIV, Israel and BETHESDA, Maryland, April 18, 2018 TEL AVIV, Israel and BETHESDA, Maryland, April 18, 2018 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in cannabinoid diagnostics for the personalized treatment of cancer, today announced the receipt of a Notice of Allowance from The Patent Office of the State of Israel. The Patent Office intends to grant Cannabics the patent for its method of high throughput screening of

    Read more
  • 1:55 PM

    ORLANDO, Fla., Sept. 06, 2017, IMUN, (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing Lodonal™, its patented, affordable, non-toxic therapy for the management of cancer, HIV, autoimmune diseases and other inflammatory conditions, today announced that it has entered into an exclusive agreement with Kenya-based Omaera Pharmaceuticals, Ltd. for the sale and distribution of Lodonal™, valued at a minimum of $31 million in revenues over three years. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/d02d7135-cf47-471f-9fa0-17fa3e9728a7. Under the

    Read more
  • 10:11 PM

      Viratech has successfully integrated and delivered to the Cancer.im. Social Network, an Approved Apple IOS Application for iPhones and iPads RENO NV – Viratech Corp. (the “Company”) (OTC PINK: VIRA) is an open source mobile & social knowledge networking technology company, focused on creating Social Network Application Platforms (SNAPs), specifically, social network driven wikis, harnessing social collaboration in a way to give the user a more in depth perspective of a researched subject or action, announced today that it

    Read more
  • 10:06 PM

    The Robert Ryan Cancer Protocol is based on the pioneeering work of Dr. Nicos Nikolau, who in October of 2007 published a study titled “Quality of Life (QOL) Supersedes the Classic Predictors of Survival in Locally Advanced Non Small Cell Lung Cancer”  This Rosetta Stone study was the first time that a qualiatitve measure (Quality of Life) was validated in an evidenced based medicine study to have validated medical benefit. Leveraging the EORTC (European Organization for the Research and Treatment of

    Read more
  • 10:40 AM

    The Company may be the first to offer an all-natural ‘cancer cocktail’ combining the therapeutic benefits of the plant and animal kingdoms PR Newswire, PTLF HANCOCK, Maryland, June 14, 2017 HANCOCK, Maryland, June 14, 2017 /PRNewswire/ — PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the “Company”), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, reports on its solution to the ever increasing problem of drug resistance and high toxicity in the treatment of cancer in

    Read more
  • 4:22 PM

    TEL AVIV, Israel, April 3, 2017, CNBX, /PRNewswire/ — Cannabics Pharmaceuticals Inc. (CNBX) is pleased to announce that it received the final report of the research held in the Technion Israel Institute of Technology, in which the antitumor activity of cannabinoids was reflected in several types of cancer (breast, ovarian, colon, pancreatic, gastric, glioblastoma). The results which were obtained, using High Throughput Screening technology (HTS), clearly indicate that the company’s cannabinoid compounds caused apoptosis (programed cancer cell death) in all

    Read more
Public Wire Banner